CHEMICAL SCREENING AND OPTIMIZATION FACILITY (CSOF) – DRUG AND SUBSTANCE

尤尼斯·肯尼迪·施莱弗国家儿童健康和人类发展研究所的避孕研究处（CRB）支持研究开发能够破坏卵子发生、精子发生、排卵、精子成熟和/或功能的化合物，为男性和/或女性提供安全有效的避孕药具。化学筛选和优化设备（CSOF）通过识别、优化和进行具有避孕效果的分子制剂的小规模生产，发挥了独特的作用。CSOF提供全面的项目管理和支持这些目标的能力，以配合新的避孕方法的开发：这些包括但不限于重组肽和蛋白质的生成、分析开发、高通量筛选（HTS）、x射线晶体学、计算化学、药物化学和药理学。经CSOF鉴定和/或优化的化合物将按照非良好生产规范（non-GMP）制备，以进行进一步的临床前评价。CSOF在CRB的药物开发任务中起着至关重要的作用。

The Contraception Research Branch (CRB) within the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) supports research to develop compounds that can disrupt oogenesis, spermatogenesis, ovulation, sperm maturation and/or function affording safe and effective contraceptives for men and/or women. The Chemical Screening and Optimization Facility (CSOF) fulfills a unique role by identifying, optimizing, and conducting small scale production of molecular agents that achieve a contraceptive effect. The CSOF provides overall project management and the capabilities to support these objectives pursuant to development of new contraceptive methods: these include, but are not limited to, the generation of recombinant peptides and proteins, assay development, high throughput screening (HTS), x-ray crystallography, computational chemistry, medicinal chemistry, and pharmacology. Compounds identified and/or optimized by the CSOF will be prepared under non-Good Manufacturing Practices (non-GMP) for further preclinical evaluation. The CSOF plays a critical role in the drug development mission of the CRB.